# Intra-arterial Chemotherapy With Melphalan for the Treatment of Retinoblastoma (RTB) in Advanced Intraocular Stage

> **NCT01393769** · PHASE2 · TERMINATED · sponsor: **Hospital Sant Joan de Deu** · enrollment: 5 (actual)

## Conditions studied

- Retinoblastoma

## Interventions

- **DRUG:** Melphalan

## Key facts

- **NCT ID:** NCT01393769
- **Lead sponsor:** Hospital Sant Joan de Deu
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-11
- **Primary completion:** 2012-12
- **Final completion:** 2013-05
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Only 5 subjects could be enrolled. Sample of 25 pat. not be achieved (rare disease).
- **Last updated:** 2016-08-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01393769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01393769, "Intra-arterial Chemotherapy With Melphalan for the Treatment of Retinoblastoma (RTB) in Advanced Intraocular Stage". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01393769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*